All Names
AlternameCRK1, CSAID binding protein, CSBP, CSBP1, CSBP2, Cytokine suppressive anti- inflammatory drug binding protein, MAP kinase MXI2, MAP kinase p38, MAPK14, MAX-interacting protein 2, MXI2, Mitogen-activated protein kinase 14, Mitogen-activated protein kinase p38, kinase p38-alpha
All SitesHuman: Thr179; Mouse: Thr179; Rat: Thr179
Form Or Antibody
Form of AntibodyRabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Storage/StabilityStore at -20℃/1 year
ImmunogenThe antiserum was produced against synthesized phosphopeptide derived from human P38 MAPK around the phosphorylation site of threonine 179 (E-M-TP-G-Y).
PurificationThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Specificty Sensitivity
Specificity/SensitivityP38 MAPK (phospho-Thr180) antibody detects endogenous levels of P38 MAPK only when phosphorylated at threonine 179.
ReferencesJeffrey W. Ryder, J. Biol. Chem., Jan 2000; 275: 1457.
Ralph G. Meyer, Eur. J. Biochem., Jan 2002; 269: 337.
Jizhong Liu, Blood, Mar 2007; 10.1182.
John M. Kyriakis and Joseph Avruch Physiol Rev, Apr 2001; 81: 807.
Research AreaAutophagy antibody Cancer Cardiovascular Cell Biology Epigenetics & Nuclear Signaling Developmental Biologys Immunology Drug Discovery Products Metabolism Neuroscience Signal Transduction Stem Cells